Piperidine and pyrrolidine analogs as glycogen synthase activators; a patent evaluation (WO2011058122)

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.1, 2012-01, pp. : 89-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benzisoxazole analogs as glycogen synthase activators, a patent evaluation (WO2011057956)

By Uto Yoshikazu

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 701-707

Informa Healthcare

Access to resources Recommend Favorite

(WO2011057959) Indole and indazole derivatives as glycogen synthase activators: a patent evaluation

By Skaltsounis Alexios-Leandros Gaboriaud-Kolar Nicolas

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 12, 2011-12 ,pp. : 1925-1929

Informa Healthcare

Access to resources Recommend Favorite

Glycopeptide antibiotic analogs efficient against vancomycin-resistant bacteria: a patent evaluation (WO2013022763)

By Olsufyeva Eugenia N Preobrazhenskaya Maria N

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1625-1634

Informa Healthcare

Access to resources Recommend Favorite

Polymyxin derivatives: a patent evaluation (WO2012168820)

By Wu Haifan

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 1075-1081

Informa Healthcare

Access to resources Recommend Favorite

Targeted antimicrobial moieties (WO2010080819): patent evaluation

By Song Zhong-Cheng Zhu Hai-Liang

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 4, 2011-04 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite